Arsenic exposure induces the warburg effect in cultured human cells

Toxicology and Applied Pharmacology

Volumn 271, Issue 1, 2013, Pages 72-77

  Zhao, Fei ^a   Severson, Paul ^a   Pacheco, Samantha ^a   Futscher, Bernard W ^a   Klimecki, Walter T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenite; Glycolysis; Hypoxia inducible factor 1; Warburg effect

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARSENIC POISONING; ARTICLE; CELL CULTURE; CULTURE MEDIUM; ENERGY YIELD; EPITHELIUM CELL; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; WARBURG EFFECT;

2-DEOXY-D-GLUCOSE; 2-DG; ARSENITE; AS; GLYCOLYSIS; HIF-1A; HYPOXIA INDUCIBLE FACTOR-1 ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR 1; WARBURG EFFECT;

ARSENITES; CELL LINE; CELLS, CULTURED; DEOXYGLUCOSE; EPITHELIAL CELLS; EXTRACELLULAR SPACE; GENE EXPRESSION; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SPACE; LACTIC ACID; LUNG; SODIUM COMPOUNDS;

EID: 84879292018     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.04.020     Document Type: Article

References (46)

1. Amster E.D., Cho J.I., Christiani D. Urine arsenic concentration and obstructive pulmonary disease in the U.S. population. J. Toxicol. Environ. Health A 2011, 74:716-727.
2. Andrew A.S., Burgess J.L., Meza M.M., Demidenko E., Waugh M.G., Hamilton J.W., Karagas M.R. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ. Health Perspect. 2006, 114:1193-1198.
3. Aposhian H.V. Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 1989, 10:265-299.
4. Argos M., Kalra T., Rathouz P.J., Chen Y., Pierce B., Parvez F., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Slavkovich V., van Geen A., Graziano J., Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010, 376:252-258.
5. Baumann K. Stem cells: a metabolic switch. Nat. Rev. Mol. Cell Biol. 2013, 14:64-65.
6. Bolt A.M., Douglas R.M., Klimecki W.T. Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicol. Lett. 2010, 199:153-159.
7. Bolt A.M., Zhao F., Pacheco S., Klimecki W.T. Arsenite-induced autophagy is associated with proteotoxicity in human lymphoblastoid cells. Toxicol. Appl. Pharmacol. 2012, 264:255-261.
8. Chen C.J., Kuo T.L., Wu M.M. Arsenic and cancers. Lancet 1988, 1:414-415.
9. Chen C.J., Chen C.W., Wu M.M., Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 1992, 66:888-892.
10. Echaniz-Laguna A., Benoilid A., Vinzio S., Fornecker L.M., Lannes B., Goulle J.P., Broly F., Mousson de Camaret B. Mitochondrial myopathy caused by arsenic trioxide therapy. Blood 2012, 119:4272-4274.
11. Flanagan S.V., Johnston R.B., Zheng Y. Arsenic in tube well water in Bangladesh: health and economic impacts and implications for arsenic mitigation. Bull. World Health Organ. 2012, 90:839-846.
12. Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J. Biol. Chem. 1995, 270:28989-28994.
13. Hamaguchi T., Iizuka N., Tsunedomi R., Hamamoto Y., Miyamoto T., Iida M., Tokuhisa Y., Sakamoto K., Takashima M., Tamesa T., Oka M. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int. J. Oncol. 2008, 33:725-731.
14. Huang C., Ma W.Y., Li J., Dong Z. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res. 1999, 59:3053-3058.
15. Ingham K.C. Protein precipitation with polyethylene glycol. Methods Enzymol. 1984, 104:351-356.
16. Jean J.C., Rich C.B., Joyce-Brady M. Hypoxia results in an HIF-1-dependent induction of brain-specific aldolase C in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L950-956.
17. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
18. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
19. Kolobova E., Tuganova A., Boulatnikov I., Popov K.M. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. Biochem. J. 2001, 358:69-77.
20. Krones A., Jungermann K., Kietzmann T. Cross-talk between the signals hypoxia and glucose at the glucose response element of the l-type pyruvate kinase gene. Endocrinology 2001, 142:2707-2718.
21. Lee C., Lee Y.M., Rice R.H. Human epidermal cell protein responses to arsenite treatment in culture. Chem. Biol. Interact. 2005, 155:43-54.
22. Li Q., Chen H., Huang X., Costa M. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Toxicol. Appl. Pharmacol. 2006, 213:245-255.
23. Lu C.W., Lin S.C., Chen K.F., Lai Y.Y., Tsai S.J. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 2008, 283:28106-28114.
24. Martin-Rendon E., Hale S.J., Ryan D., Baban D., Forde S.P., Roubelakis M., Sweeney D., Moukayed M., Harris A.L., Davies K., Watt S.M. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007, 25:1003-1012.
25. Najafov A., Alessi D.R. Uncoupling the Warburg effect from cancer. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19135-19136.
26. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 2006, 114:641-648.
27. Pavlides S., Whitaker-Menezes D., Castello-Cros R., Flomenberg N., Witkiewicz A.K., Frank P.G., Casimiro M.C., Wang C., Fortina P., Addya S., Pestell R.G., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8:3984-4001.
28. Pavlides S., Tsirigos A., Vera I., Flomenberg N., Frank P.G., Casimiro M.C., Wang C., Pestell R.G., Martinez-Outschoorn U.E., Howell A., Sotgia F., Lisanti M.P. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging 2010, 2:185-199.
29. Pelletier J., Bellot G., Gounon P., Lacas-Gervais S., Pouyssegur J., Mazure N.M. Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival. Front. Oncol. 2012, 2:18.
30. Peters R.A. Biochemistry of some toxic agents. I. Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning. Bull. Johns Hopkins Hosp. 1955, 97:1-20.
31. Porporato P.E., Dhup S., Dadhich R.K., Copetti T., Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front. Pharmacol. 2011, 2:49.
32. Samikkannu T., Chen C.H., Yih L.H., Wang A.S., Lin S.Y., Chen T.C., Jan K.Y. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 2003, 16:409-414.
33. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 2001, 13:167-171.
34. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 1994, 269:23757-23763.
35. Simeonova P.P., Luster M.I. Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol. 2004, 198:444-449.
36. Sinha D., Biswas J., Bishayee A. Nrf2-mediated redox signaling in arsenic carcinogenesis: a review. Arch. Toxicol. 2013, 87:383-396.
37. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I., Duggan H.M., Wood R., Kosnett M.J., Smith M.T. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 1992, 97:259-267.
38. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 1998, 147:660-669.
39. Smith A.H., Lingas E.O., Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull. World Health Organ. 2000, 78:1093-1103.
40. Stueckle T.A., Lu Y., Davis M.E., Wang L., Jiang B.H., Holaskova I., Schafer R., Barnett J.B., Rojanasakul Y. Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol. Appl. Pharmacol. 2012, 261:204-216.
41. Vahidnia A., van der Voet G.B., de Wolff F.A. Arsenic neurotoxicity-a review. Hum. Exp. Toxicol. 2007, 26:823-832.
42. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
43. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
44. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
45. Yu F., White S.B., Zhao Q., Lee F.S. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9630-9635.
46. Zhang T., Qi Y., Liao M., Xu M., Bower K.A., Frank J.A., Shen H.M., Luo J., Shi X., Chen G. Autophagy is a cell self-protective mechanism against arsenic-induced cell transformation. Toxicol. Sci. 2012, 130:298-308.